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Abstract Nearly all bacterial species, including pathogens,
have the ability to form biofilms. Biofilms are defined as
structured ecosystems in which microbes are attached to sur-
faces and embedded in a matrix composed of polysaccharides,
eDNA, and proteins, and their development is a multistep
process. Bacterial biofilms constitute a large medical problem
due to their extremely high resistance to various types of ther-
apeutics, including conventional antibiotics. Several environ-
mental and genetic signals control every step of biofilm de-
velopment and dispersal. From among the latter, quorum sens-
ing, cyclic diguanosine-5’-monophosphate, and small RNAs
are considered as the main regulators. The present review
describes the control role of these three regulators in the life
cycles of biofilms built by Pseudomonas aeruginosa, Staph-
ylococcus aureus, Salmonella enterica serovar Typhimurium,
and Vibrio cholerae. The interconnections between their ac-
tivities are shown. Compounds and strategies which target the
activity of these regulators, mainly quorum sensing inhibitors,
and their potential role in therapy are also assessed.
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Introduction
The majority of bacteria, including clinically relevant micro-
organisms, are able to grow in biofilms adhering to abiotic and
biotic surfaces (for a review, see Donlan and Costerton 2002).
A biofilm is defined as a structured microbial community
whose development requires a significant change in bacterial
physiology and results in increased tolerance to exogenous
stress, including treatment with antibiotics and other biocides
(Hall-Stoodley and Stoodley 2009). Bacterial biofilms can
form a monolayer or, most frequently, multilayers in which
bacteria are attached both to the surface and to neighboring
bacteria by an extracellular matrix consisting of polysaccha-
rides, proteins, and DNA (Karatan and Watnick 2009). The
biofilm formation process always has several stages that in-
clude: (i) attachment to the carrier surface, (ii) reversible,
followed by irreversible, binding to the surface with the par-
ticipation of adhesins, (iii) development of microcolonies, and
(iv) maturation of biofilm architecture (Donlan 2001). Under
unfavorable conditions, the synthesis of matrix compounds
decreases and the matrix is enzymatically cleaved, leading to
biofilm dispersion (Gjermansen et al. 2005). A scheme of the
biofilm life cycle is presented in Fig. 1.
Biofilm formation and dispersal are highly controlled process-
es regulated at the genetic level and by environmental signals.
Current knowledge points to quorum sensing (QS), bis-(3’-5’)-
cyclic diguanosine monophosphate (c-di-GMP), and small
RNAs (sRNAs) as the main regulators of bacterial biofilms, at
least in several Gram-negative species (Fazli et al. 2014).
QS is considered a special Blanguage^ used for intercellular
communication, which is based on small, self-generated sig-
nal molecules called autoinducers. When sufficient bacteria
are present and the concentration of autoinducers reaches a
threshold level, the bacteria start to sense their critical mass
and answer by repressing or activating target genes (de Kievit
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and Iglewski 2000). QS-controlled genes can constitute
around 10 % of the bacterial genome (Wagner et al. 2003).
QS systems play a very important role during the development
and dispersal of bacterial biofilms. Although these systems are
not involved in the attachment and initial biofilm growth
stages, they are required for further biofilm development
and, also, are the main regulators of biofilm dispersal (Davies
et al. 1998). The QS signaling pathways in Pseudomonas
aeruginosa, Staphylococcus aureus, and Vibrio cholerae are
shown in Fig. 2.
The secondmain biofilm regulator, the c-di-GMP signaling
network, is considered the most complex secondary signaling
system discovered in bacteria. However, its complexity varies
significantly and this type of signaling is absent in some bac-
teria (Römling and Balsalobre 2012). After binding to a vari-
ety of cellular receptors, c-di-GMP controls bacterial tran-
scription, the activity of enzymes, and even the functioning
of larger cellular structures (Hengge 2009). c-di-GMP plays a
crucial role in the bacterial decision between planktonic and
biofilm-associated lifestyle (Jenal andMalone 2006). The fac-
tors regulated by c-di-GMP and important for three-
dimensional biofilm structure development are: synthesis of
exopolysaccharides, adhesive pili and adhesins, secretion of
extracellular DNA (eDNA), and also control of cell death and
motility. Regulatory connections between QS and c-di-GMP
have been proved; it has been shown that cell density itself is
one of the environmental cues sensed by the c-di-GMP net-
work (Strivastava and Waters 2012).
Finally, small non-coding RNA molecules, sRNAs, in-
cluding riboswitches, have been shown to participate in
post-transcriptional gene regulation in bacteria, involving
a range of metabolic processes, adaptation to stress, and
microbial pathogenesis (for a review, see Michaux et al.
2014; Mandin and Guillier 2013). Therefore, sRNA regu-
lators have become powerful tools for metabolic engineer-
ing and synthetic biology (Kang et al. 2014). However, the
amount of data pointing to the role of sRNA in the biofilm
life cycle is rather limited.
From among the other factors involved in biofilm forma-
tion, which are beyond the scope of this review, horizontal
gene transfer (Madsen et al. 2012), alternative sigma factors
(Irie et al. 2010), and toxin–antitoxin systems (Wang and
Wood 2011) should be mentioned.
The control of bacterial biofilm has been studied
mainly in members of the genus Pseudomonas, including
the human opportunistic pathogen, P. aeruginosa, but the
number of papers describing biofilm regulation in other
bacterial pathogens is now growing exponentially. This
knowledge may be useful in biofilm manipulation, con-
trol, and eradication. The present review describes the
genetics of biofilm development in representative bacte-
















Fig. 1 Subsequent stages of
bacterial biofilm formation/
dispersal and their genetic regu-
lation. (i) reversible, followed by
irreversible, attachment to the
surface, (ii) formation of
microcolonies, (iii and iv) biofilm
maturation leading to the forma-
tion of bacterial consortia, and (v)
biofilm dispersal. The regulatory
involvement of quorum sensing
(QS), bis-(3’-5’)-cyclic
diguanosine monophosphate (c-
di-GMP), and small RNAs
(sRNAs) is shown by the arrows
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The strategies of biofilm eradication, mainly those
exploiting QS control, are also discussed.
Pseudomonas aeruginosa biofilms
Brief characteristics
P. aeruginosa is an aerobic, non-fermenting, Gram-negative
rod that has become a major opportunistic human pathogen
and the leading cause of nosocomial infections in cancer,
transplantation, and cystic fibrosis (CF) patients. Furthermore,
due to its ability to cause chronic lung infections, this species
is the primary pathogen responsible for the mortality of pa-
tients with CF (Silby et al. 2011). Many reports describe
P. aeruginosa as being also one of the main species found in
dermal and burn wounds (Ammons et al. 2009). In this spe-
cies, exopolysaccharides appear to be the most important ma-
trix components, in contrast to the other members of the genus
Pseudomonas, P. putida and P. fluorescens, where this role is
played by large surface proteins, among them the most abun-
dant is large adhesion protein, LapA (Fazli et al. 2014).
P. aeruginosa produces at least three secreted polysaccharides,
Pel, Psl, and alginate. The last one produced bymucoid strains
is considered as a P. aeruginosa virulence factor and, next to
another compound of matrix, eDNA, seems to be of particular
relevance to biofilm-mediated antibiotic resistance (Aspe et al.
2012). Three alreadymentionedmain systems based onQS, c-
di-GMP signaling, or regulatory sRNA control P. aeruginosa
biofilm formation and dispersal. Their mode of action is de-
scribed below. All systems follow the same scheme of signal
transduction pathway, starting from sensors, followed by sig-
nal transmitters, and ending in effectors, which, in turn, exe-
cute the outcome, i.e., the production or modulation of factors
involved in biofilm formation and detachment. The overview
of these regulatory pathways is outlined in Fig. 3. The control
of biofilm development in two other species of the genus
Pseudomonas, P. fluorescens and P. putida, commonly found
in soil and plant rhizosphere, and in an opportunistic patho-
gen, Burkholderia cenocepacia infecting CF patients, gener-
ally follow the outline described for P. aeruginosa. However,
quite serious differences are observed concerning the impor-
tance of the main regulatory pathways and also the involve-
ment of additional regulatory factors (Fazli et al. 2014).
Quorum sensing (QS)
QS regulation of biofilm-related genes in P. aeruginosa in the
natural environment and during persistent infections is con-
sidered as the best known example among all bacterial species
(Singh et al. 2000). This bacterium has at least three QS sys-
tems: two N-acylated homoserine lactone (AHL)-based LasIR
and RhlIR systems and a Pseudomonas quinolone signal
(PQS)-based system. Both AHL systems contain a gene
encoding AHL sensor/transcriptional regulator, lasR and rhlR,
respectively, and a gene encoding an autoinducer, lasI, re-
















































Fig. 2 Schematic representation of QS system. a Pseudomonas
aeruginosa LasI, RhlI, and PqsABCDH synthesize the QS signal
molecules: N-(3-oxo-dodecanoyl)-L-homoserine lactone (3OC12-
AHL), C4-AHL, and 2-heptyl-3-hydroxy-4-quinolone (PQS),
respectively. The transcription factors LasR, RhlR, and PqsR detect
their respective signal molecules, resulting in the regulation of target
genes transcription. b Staphylococcus aureus QS peptide AIP is
synthesized as a longer precursor by AgrD and is processed and
secreted via AgrB. The extracellular signal is detected by the
membrane-located histidine kinase AgrC and signal transduction occurs
by phosphorelay to the AgrA response regulator. In the second QS sys-
tem, LuxS synthes izes AI-2 , which inhib i t s PIA/PNAG
exopolysaccharide synthesis through an unknown QS cascade. c Vibrio
cholerae LuxS and CqsA synthesize AI-2 and CAI-1 signal molecules,
respectively. These signal molecules are detected by their corresponding
receptors, the two-component histidine kinases LuxPQ and CpqS, which
transfer phosphate residue to transcription activator LuxO. The regulation
by LuxO–P is presented in Fig. 5
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homoserine lactone and rhlI responsible for the synthesis of
N-(butanoyl)-L-homoserine lactone (C4-AHL) (Pearson et al.
1994, 1995). In the PQS system, 2-heptyl-3-hydroxy-4-quin-
olone transported by outer membrane vesicles (OMVs) is a
sensing molecule, and, in turn, PQS causes the biogenesis of
OMVs (Mashburn-Warren et al. 2008; Kulkarni and
Jagannadham 2014). All three systems are regulated hierar-
chically: LasR positively regulates RhlR and PQS and RhlR
negatively regulates PQS (Pesci et al. 1997;Wade et al. 2005).
QS signaling controls the synthesis of rhamnolipids, which
are important in the late stage of biofilm development, main-
taining the channels in mushroom-shaped structures, resulting
in the proper distribution of nutrient and oxygen and removal of
waste products (Davey and O’Toole 2000). Rhamnolipids syn-
thesis is induced in the center of biofilmmushroom caps, which
is consistent with the control role of QS (Lequette and
Greenberg 2005). The overproduction of these biosurfactants
causes the biofilm detachment from the surface, leading to its
dispersal (Boles et al. 2005). QS also plays a role in the release
of a large amount of eDNA at the late stage of biofilm devel-
opment, as a consequence of the autolysis of a bacterial sub-
population (Allesen-Holm et al. 2006). It is well established
that autolysis is regulated by PQS, but the mechanism of this
process is still not fully understood (Fazli et al. 2014). The QS
system regulates the production of yet other compounds impor-
tant for biofilm formation, i.e., LecA and LecB lectins (Tielker
et al. 2005; Diggle et al. 2006) and siderophores pyoverdine
and pyochelin (Banin et al. 2005). The last two exert their
action through participation in iron metabolism; it was shown
that too low or too high concentration of iron results in the
inhibition of biofilm formation (Singh et al. 2002).
c-di-GMP signaling
In general, high c-di-GMP level induces the biosynthesis of
adhesins and matrix polysaccharides and inhibits various types
of motility and, therefore, stimulates biofilm formation. In con-
trast, low c-di-GMP level downregulates the production of
adhesins and exopolysaccharides and enhances bacterial motil-
ity, leading to biofilm dispersal (for a review, see Hengge 2009).
Two types of enzymes control the level of c-di-GMP in bacteria.
Diguanylate cyclases (DGCs), which contain typical domain,
CGDEF, produce this nucleotide from two molecules of GTP,
whereas c-di-GMP is broken down into 5’-phosphoguanylyl-(3’-
5’) guanosine (pGpG) by specific photodiesterases (PDEs),
which activity is associated with EAL or HD-GYP specific do-
mains. The activity of both types of enzymes is controlled by
environmental cues (Römling et al. 2013).
In P. aeruginosa, the so-called Bbasic c-di-GMP signaling
module^ consists of five components: (i) sensors of environ-
mental signals, (ii) enzymes involved in the synthesis and
degradation of c-di-GMP (see above), (iii) specific effectors
which can be proteins or riboswitches, both being allosterical-
ly regulated by c-di-GMP, (iv) targets, e.g., promoter DNA,
enzymes, or cellular structures such as flagellar basal body or
exopolysaccharide synthetic and secretion apparatus, (v) mo-
lecular output produced by effectors after their activation by c-
di-GMP (Hengge 2009).
P. aeruginosa contains three signal sensors (receptors),
WspA, YfiB, and RocS1, which sense the level of c-di-
GMP, five diguanylate cyclases, WspR, YfiN, SadC, RoeA,
and SiaD, and five phosphodiesterases, BifA, DipA, RocR,
MucR, and NbdA. The best characterized chemosensor,
WspA, senses growth on surfaces and then becomes activated
and able to phosphorylate its cognate diguanylate cyclase,
WspR (Güvener and Harwood 2007). While phosphorylated,
WspR forms clusters, changes the location within the cell, and
its cyclase activity is increased (Huangyutitham et al. 2013).
Yet another sensor, the outer membrane protein YfiB, re-
sponds to cell membrane stress and activates YfiN cyclase
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Fig. 3 Control of biofilm formation in P. aeruginosa. Three control
pathways are shown. In two AHL-based QS pathways, cell density plays
a role of the environmental signal. The signal is then transferred through
the transmitter proteins LasI and RhlI to the effector proteins LasR and
RhlR, being transcriptional regulators. The QS system controls the syn-
thesis of rhamnolipids and secretion of eDNA. In c-di-GMP signaling, the
level of c-di-GMP is sensed by sensor proteins—receptors which govern
the metabolism of this molecule through the activity of diguanylate cy-
clases (DCGs) and phosphodiesterases (PDEs). Upon binding to the ef-
fector proteins, which are activators or repressors acting at transcriptional
or post-transcriptional levels, c-di-GMP controls the synthesis of adhesins
and exopolysaccharides and inhibits the motility. The control by sRNA
involves the activation of sensor kinases, e.g., GacS, which phosphory-
lates transmitter protein GacA, leading to the subsequent activation of
small RNAs, inhibition of effector RsmA activity, and, finally, to the
inhibition of exopolysaccharides synthesis and enhancement of motility
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(Malone et al. 2012). PDEs enzymes causing biofilm dispersal
are activated by such environmental cues as starvation, low
concentration of oxygen, and nitric acid, but their precise
mechanism of activation has not been elucidated (An et al.
2010; Li et al. 2013). The multitude of sensors, as well as c-
di-GMP synthesizing and breaking enzymes, allows the c-di-
GMP to be controlled by various environmental cues.
Four P. aeruginosa effectors, Alg44, FleQ, PelD, and FimX,
regulate different targets involved in biofilm development.
Alg44 activated by c-di-GMP controls the synthesis of alginate,
an exopolysaccharide important in the late stages of infection
with P. aeruginosa mucoid strains (Merighi et al. 2007). FleQ
acts as both a repressor and an activator of pel operon encoding
Pel exopolysaccharide synthesis (Baraquet and Harwood
2013), regulates the synthesis and transport of outer membrane
adhesin, CdrA (Borlee et al. 2010), and represses the expression
of flagellum biosynthesis genes (Baraquet and Harwood 2013).
Two other effectors, PelD and FimX, regulate Pel synthesis at a
post-transcriptional level and control twitching motility (Lee
et al. 2007; Jain et al. 2012).
Control by sRNA
Regulation by sRNAs, rsmYand rsmZ, is the best known exam-
ple. In this pathway, the role of a sensor is played by three sensor
kinases, RetS, LadS, but mainly GacS (Ventre et al. 2006). GacS
phosphorylates GacA (Goodman et al. 2009), which, in turn,
activates the transcription of rsmZ and rsmY. These two sRNAs
are also controlled by the other proteins participating in the
P. aeruginosa phosphorelay system (Petrova and Sauer 2010).
rsmZ and rsmY reduce the activity of effector protein RsmA,
being a negative post-transcriptional regulator of the biofilm ma-
trix polysaccharide Psl (Irie et al. 2010), and also downregulate
another effector, RsmN, controlling the same functions as RsmA
(Marden et al. 2013). It was shown that an increased expression
of rsmYand rsmZ results in enhanced initial attachment to abiotic
surfaces but, on the contrary, subsequent biofilm development is
hampered by the high level of these sRNAs (Chambers and
Sauer 2013). Another sRNA, phrS, stimulates the P. aeruginosa
PQS pathway. phrS expression requires global oxygen-
responsible regulator ANR, which provides a regulatory link
between oxygen availability and PQS (Sonnleitner et al. 2011).
The list of factors controlling P. aeruginosa biofilm
development should be extended by the alternative sig-
ma factor, RpoS. It was shown that, in P. aeruginosa,
PAO1 biofilm rpoS expression is increased (Waite et al.
2006) and RpoS acts as a positive regulator of the ex-
pression of the psl gene (Irie et al. 2010). Finally, it
was postulated that yet another, fatty, cis-2-decenoic ac-
id-mediated, signaling may play a role in biofilm dis-
persal (Amari et al. 2013). However, the mechanism of
its activity has not yet been resolved.
Staphylococcus aureus biofilms
Brief characteristics
S. aureus is a Gram-positive, nonmotile coccus able to form
cell clusters and producing yellow pigment. This bacterium is
a causative agent of acute and chronic infections. Its ecologi-
cal niche in humans is the anterior nares. S. aureus biofilm
persists on medical implants and catheters, constituting a sig-
nificant healthcare problem (Kiedrowski and Horswill 2011).
The list of S. aureus biofilm-related diseases is long and in-
cludes: osteomyelitis, indwelling medical device infections,
periodontitis and peri-implantitis, chronic wound infection,
chronic rhinosinusitis, endocarditis, and ocular infections
(for a review, see Archer et al. 2011).
S. aureus biofilm life cycle follows the typical scheme al-
ready described for P. aeruginosa. Due to its lack of motility,
the biofilm is flatter than those formed by motile genera, al-
though mushroom forms can also be observed (Mann et al.
2009). In the biofilm, a great number of slow-growing cells
and persister cells—nondividing and tolerant to antibiotics—
are present (Lewis 2007). S. aureus biofilm is embedded with-
in a glycocalyx or slime layer composed primarily of teichoic
acid and staphylococcal and host proteins (Husain et al. 2013).
The polysaccharide PIA (polysaccharide intercellular anti-
gen), composed mainly of polymeric N-acetyl-glucosamine
and eDNA, is also a significant biofilm constituent. The ge-
netic control of PIA synthetic operon, icaADBC, involves
many factors, among them the main IcaR repressor and the
second TcaR repressor (Cramton et al. 1999; Jefferson et al.
2004). The expression of icaR gene is positively regulated by
protein Spx (suppressor of clpP and clpX), a global regulator
of stress response and negatively regulated by Rbf protein
(Cue et al. 2009; Pamp et al. 2006). Moreover, SrrAB (staph-
ylococcal respiratory response regulator) is responsible for
PIA induction under anaerobic conditions (Ulrich et al.
2007). It was shown that biofilm formation in several S. aureus
strains, including MRSA (methicillin-resistant S. aureus),
does not depend on PIA production (Fitzpatrick et al. 2005),
which is substituted by proteinaceous cell-to-cell adhesion
with the participation of, e.g., biofilm-associated protein,
Bap (Lasa and Penadés 2006). Another important component
of staphylococcal biofilm, eDNA, is released as a conse-
quence of cell lysis by holin homolog CidA and other proteins
(Rice et al. 2007; Brady et al. 2006). However, massive cell
lysis takes place at the late stage of biofilm development,
eDNA is also released at an early stage, thus participating in
cell attachment (Mann et al. 2009). In highly aggressive
S. aureus isolates, a novel toxin family, phenol-soluble
modulins (PSMs), contributes to biofilm development and
dispersal and, therefore, also in the dissemination of biofilm-
associated infections (Peschel and Otto 2013). It should be
noted here that appreciable strain-dependent variations across
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staphylococcal biofilm composition are observed (Kiedrowski
and Horswill 2011).
S. aureus biofilm development is regulated by many envi-
ronmental conditions and genetic signals. From among the
latter, the most important are QS and control by small mole-
cules, including sRNA.
Control by QS, c-di-GMP, and sRNA
The accessory gene regulator (Agr) system plays a crucial role
in the functioning of the S. aureusQS system. In this genus, QS
positively regulates toxins and acute virulence factors and neg-
atively regulates surface proteins namedmicrobial surface com-
ponents recogniz ing adhesive matr ix molecules
(MSCRAMMs), thus inhibiting adhesion to human matrix pro-
teins, e.g., fibrinogen (Clarke and Foster 2006; Pei et al. 1999).
QS also enhances cell detachment from mature biofilm.
The agr locus contains agrA, agrC, agrD, and agrB genes,
consti tut ing the so-called transcript RNAII. The
prepheromone AgrD is exported and modified by AgrB,
which results in formation of the characteristic thiolactone-
containing autoinducing peptide (AIP). AIP activates the
two-component AgrC/AgrA system, which, in turn, activates
the transcription of RNAII, providing an autofeedback loop (Ji
et al. 1995). AIP also influences the transcription of bifunc-
tional RNAIII regulating MSCRAMMs and encoding d-
hemolysin (Fechter et al. 2014). The expression of psm genes
coding for PSMs surfactants responsible for biofilm matura-
tion and dispersal by the disruption of noncovalent interac-
tions between biofilm cells and matrix components are also
under the influence of the QS system (Periasamy et al. 2012;
Otto 2014). The staphylococcal QS system upregulates the
expression of peptidases and nucleases, which also increases
biofilm detachment (Boles and Horswill 2008; Lauderdale
et al. 2009). The data of several experiments support the in-
hibitory role of QS on biofilm development; for example, it
was demonstrated that agr mutants form a thicker biofilm
compared with wild-type strains (Vuong et al. 2003).
It was postulated that the ability to form a biofilm is closely
related to the character of infection, and the determinants of
acute and chronic virulence are regulated byQS in an opposite
fashion. QS is important in expressing acute virulence and the
formation of a differentiated biofilm with the capacity for
dissemination, whereas chronic infections are concomitant
with biofilm downregulation and mutation in the QS system.
This postulate is supported by the observation that QSmutants
are found in elevated numbers in chronic infections (Shopsin
et al. 2010). However, it was recently shown that a significant
fraction of S. aureus bacteremia cases are caused by agr-de-
fective strains; thus, the role of QS in invasive staphylococcal
infections can be questionable (Painter et al. 2014).
The data on c-di-GMP involvement in S. aureus biofilm
formation seems to be controversial. Ishihara and coworkers
(2009) suggested that this nucleotide is important for biofilm
formation because a mutation in GdpS protein containing the
GGDEF domain characteristic for diguanylate cyclases ham-
pers its development. This defect was complemented by the
addition of external c-di-GMP in physiological concentration.
Opposite results were obtained by Holland and coworkers
(2008) who demonstrated that, however, GdpS does, in fact,
affect biofilm formation, but the mechanism of its activity is
independent of c-di-GMP. The reason for the reported discrep-
ancy can be due to physiological differences between the
strains used. It was also shown that the treatment of S. aureus
with extracellular c-di-GMP applied in high concentration,
ranging between 0.02 and 0.2 μM, suppressed biofilm forma-
tion by the inhibition of intercellular adhesive interactions
(Karaolis et al. 2005). These authors even suggested that c-
di-GMP can be used as a novel anti-biofilm agent.
In S. aureus, 250 sRNA genes were discovered; however,
functional studies are still lagging behind (Romilly et al.
2012). It was shown that the 3’ domain of the alreadymentioned
RNAIII transcript represses, at the post-transcriptional level, the
synthesis of cell-wall hydrolytic enzymes and, thus, negatively
influences biofilm formation (Boisset et al. 2007). In a similar
way, the 3’ untranslated domain of icaR transcript encoding a
transcriptional repressor of biofilm polysaccharide synthesis in-
terferes with the translation initiation of its own RNA (Ruiz de
los Mozos et al. 2013). It was also shown that the 5’ untranslat-
ed, 196 nucleotides long, region of sarA transcript, designated
teg49, induces the formation of biofilm through the positive
regulation of the sar locus encoding SarA protein, promoting
the initial steps of biofilm formation (Kim et al. 2014).
Two other major factors relevant for biofilm development in
S. aureus are SarA (staphylococcal accessory regulator) and
SigB. The sarA transcript is upregulated in biofilm when com-
pared to planktonic cultures (Beenken et al. 2003) and its product
inhibits the expression of nuclease Nuc and also proteases, thus
preventing the degradation of biofilm structural components
(Tsang et al. 2008). It was shown that SarA regulates the expres-
sion of cell wall-associated and certain extracellular proteins in
agr-dependent and agr-independent pathways (Arya and Princy
2013). In turn, an alternative sigma factor, SigB (Kullik and
Giachino 1997), is involved in the early stages of biofilm forma-
tion. It was shown that sigB-deficient S. aureus does not form a
biofilm and upregulates RNAIII, which promotes the antibiofilm
Agr system (Rachid et al. 2000).
The factors involved in S. aureus biofilm formation, main-
tenance, and detachment are presented in Fig. 4.
Biofilms of the enteric bacteria Salmonella
Typhimurium and Vibrio cholerae
Gastrointestinal diseases usually arise upon the ingestion of
food or water contaminated by enteric bacterial pathogens
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(Fàbrega and Vila 2013). Microorganisms frequently associ-
ated with illness are Salmonella enterica serovars,
Escherichia coli pathovars, Shigella spp., Campylobacter
spp., Yersinia enterocolitica, V. cholerae, and Listeria
monocytogenes. The genetics of biofilm formation and dis-
persal are the most intensively studied in S. enterica sv.
Typhimurium and V. cholerae.
Salmonella enterica serovar Typhimurium
The ability to form a biofilm is an important factor of
Salmonella virulence. For example, S. enterica serovar Typhi
frequently forms biofilms on gallstones, resulting in a chronic
infection of the gall bladder and the development of
Salmonella carrier state—a serious public health problem
(Gonzalez-Escobedo et al. 2011). Striking similarities in bio-
film composition and regulatory circuits between several
serovars of S. enterica and E. coli have been shown. The
control of various stages of biofilm development is the best
studied in S. enterica sv. Typhimurium, the most common
causal agents of gastrointestinal diseases.
S. Typhimurium biofilm matrix is composed of proteins
and exopolysaccharides. A major protein component is curli
(amyloid fimbriae), encoded by csg operons (Yaron and
Römling 2014). Protein BapA constitutes another important
component of the matrix (Barnhart and Chapman 2006) and
major biofilm exopolysaccharides are cellulose (Zogaj et al.
2001) and colonic acid (Gibson et al. 2006). Adhesion-
mediated type I fimbriae, Lpf and Pef, also contribute to the
early steps of biofilm formation (Ledeboer et al. 2006).
Biofilm formation is controlled by the master regulator,
CsgD protein, belonging to the LuxR family of regulators.
csgD expression is positively regulated by an alternative sig-
ma factor, σs; thus, the level of CsgD is high in the stationary
phase of growth (Yaron and Römling 2014). CsgD increases
curli and Bap expression and also, post-transcriptionally, indi-
rectly activates cellulose biosynthesis (Fàbrega and Vila
2013). In the regulation of S. Typhimurium biofilm, c-di-
GMP and sRNA play a crucial role. The elevated level of
CsgD activates the transcription of the adrA gene encoding
diguanylate cyclase synthesizing signal molecule c-di-GMP.
In turn, c-di-GMP activates csgD expression in a complex
way, involving at least eight GG(D/E)EF/EAL domain pro-
teins (Ahmad et al. 2011; Anwar et al. 2014; Römling 2012).
Moreover, c-di-GMP modulates cellulose biosynthesis
(Latasa et al. 2005) and is responsible for the so-called rdar
morphotype (red, dry, rough), characteristic for a potent bio-
film producer (Ahmad et al. 2011). In addition to c-di-GMP,
CsgD synthesis is also regulated at the post-transcriptional
level by sRNAs. csgD mRNA is a direct target for several
sRNAs, McaS, RprA, OmrA/OmrB, and possibly GcvB. All
these sRNAs negatively regulate CsgD synthesis by binding
to the overlapping 5’-region of the transcript, masking the
ribosome binding site and, thus, inhibiting translation or in-
ducing mRNA degradation (Mika and Hengge 2013). The
principles of the regulation of S. Typhimurium biofilm are
outlined in Fig. 4.
Vibrio cholerae
V. cholerae is a ubiquitous bacterium in aquatic systems but
also causes cholera, a severe diarrheal disease resulting from
the consumption of contaminated drinking water (Faruque
et al. 1998). It has a capacity to form biofilm, in both aquatic
ecosystems and within the host (Watnick and Kolter 1999).
The initial stages of biofilm formation are promoted by
flagella-mediated motility and three types of pili (Yildiz and
Visick 2009). The biofilm matrix is composed of Vibrio poly-
saccharide (VPS) containing glucose and galactose and minor
constituents, N-acetyl glucosamine, mannose, and xylose
(Yildiz and Schoolnik 1999), and matrix proteins RbmA,
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Fig. 4 Control of biofilm formation in S. aureus and S. Typhimurium.
S. aureus: biofilm control by five main regulatory factors is shown. QS
positively regulates the synthesis of detergent-like peptides, proteases,
and nucleases, resulting in biofilm dispersal. The involvement of c-di-
GMP and sRNAs in biofilm regulation is still controversial, and the
mechanism of their activity is unknown. SarA inhibits the expression of
proteases and nucleases and, thus, promotes the development of immature
biofilm. Alternative sigma factor SigB promotes the expression of adher-
ence factors and, thus, positively regulates the initial steps of biofilm
formation. S. Typhimurium: c-di-GMP activates the master CsgD and,
subsequently, increases the synthesis of curli, Bap, and cellulose. Several
sRNAs (McaS, RprA, OmrA/B, and possibly GcvB) inhibit the transla-
tion of CsgD mRNA and inhibit biofilm development
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Bap1 (Berk et al. 2012). The positive regulators of VPS pro-
duction are the proteins VpsR and VpsT, which promote the
transcription of vps structural genes (Yildiz et al. 2004;
Casper-Lindley and Yildiz 2004). Biofilm formation in
V. cholerae is regulated by QS, c-di-GMP, and sRNA. Very
tight regulatory connections between these three factors have
been proven (Srivastava and Waters 2012).
The formation of V. cholerae biofilm is induced at low cell
density and repressed at high cell density (Ng and Bassler
2009). The Vibrio QS system is composed of two sensory
circuits that respond to two different autoinducers: Als–AI-2
or a hydroxylated alkyl ketone, CAI-1 (Higgins et al. 2007;
Tiaden et al. 2010). At low concentrations of inducers, the
periplasmic receptors, respectively, histidine kinases LuxPQ
and CpqS, phosphorylate the response regulator LuxO. When
phosphorylated, LuxO activates the expression of four small
RNAs, Qrr 1–4 (quorum-regulated RNAs). These RNAs are
transcriptionally activated not only by LuxO–P but also by an
alternative σ54, and their activity appears to require the RNA-
binding chaperone Hfq (Bardill and Hammer 2012; Lilley and
Bassler 2000). Qrrs repress the synthesis of protein HapR, a
negative regulator of c-di-GMP synthesis, and, at the same
time, enhance the production of c-di-GMP synthesizing en-
zymes. Control of the c-di-GMP level by QS and Qrr consti-
tutes a complicated circuit, moreover in that V. cholerae con-
tains 61 predicted enzymes involved in the synthesis/
degradation of this nucleotide (Galperin 2004). Summarizing,
the activity of Qrr results in high c-di-GMP level at low cell
density. c-di-GMP positively controls biofilm development by
binding to VpsR and VpsT, which are the direct activators of
biofilm genes (Hammer and Bassler 2003; Vance et al. 2003;
Srivastava andWaters 2012). The control of biofilm formation
in V. cholerae is schematically presented in Fig. 5.
At high cell density, the interaction of inducers and recep-
tors switches their activity to phosphatases and LuxO is de-
phosphorylated. As a result, Qrr level decreases, HapR protein
is synthesized, c-di-GMP level drops, and biofilm formation is
inhibited (Tu and Bassler 2007). Repression of biofilm forma-
tion at high cell density could lead to the dispersal of mature
V. cholerae biofilm (Srivastava and Waters 2012). Histone-
like protein, H-NS, is another factor involved in the negative
control of V. cholerae biofilm (Teschler et al. 2015).
It was also shown that, in addition to c-di-GMP, other nu-
cleotides control V. cholerae biofilm; cAMP represses biofilm
formation (Liang et al. 2007), while ppGpp positively regu-
lates this process (He et al. 2012).
Targeting genetic determinants as a mode of biofilm
modulation
A study aimed to discover new promising agents and strate-
gies against bacterial infections, especially those associated
with biofilms, is an urgent task due to biofilm resistance to
already used antimicrobial agents. Innovative anti-biofilm
strategies are the subject of recent reviews (Cushnie and Lamb
2011; Joo and Otto 2012; Römling and Balsalobre 2012;
Markowska et al. 2013; Chung and Toh 2014; Masák et al.
2014; Tan et al. 2014).
QS inhibition, also called quorum quenching, QQ, is con-
sidered one of the promising anti-biofilm strategies. However,
the recent view of the role of QS in infections, pointing to its
importance in biofilm dispersal, provides an argument against
the practical use of the QQ approach to cure diseases caused
by biofilm (Otto 2014). Many compounds, both natural and
synthetic, affect bacterial QS systems (Kalia 2013), thus
influencing biofilm development. Two of them, vanillin and
cinnamic acid, were even shown to stimulate the formation of
biofilm due to their ability to induce AHL synthesis (Plyuta
et al. 2013). Unfortunately, up to 2014, only two clinical trials
on QS inhibitors have been performed (Scutera et al. 2014).
The ideal QS inhibitors should fulfill the following criteria:
(i) they should be low molecular weight and stable com-
pounds, (ii) their activity should be highly specific and not
toxic for the eukaryotic hosts, (iii) they should not interfere
with the basal metabolic processes that can be targets for the
development of drug resistance (Bhardwaj et al. 2013).
There are several potential classes of QS inhibiting strate-
gies. One class targets QS signal production. For example, it
was demonstrated that the analog of methylthioadenosine/S-
adenosylhomocysteine nucleosidase (MTAM) blocks AI-1



















Fig. 5 Control of biofilm development in Vibrio cholerae at low cell
density. At low concentration of autoinducers, histidine kinases LuxP
and CpqS are phosphorylated and able to phosphorylate regulator
LuxO. LuxO–P activate the expression of Qrr 1–4 RNAs, which, in
turn, positively influence the level of c-di-GMP. c-di-GMP activates
VpsR and VpsT proteins, which positively regulate biofilm genes
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et al. 2009), methyl anthranilate inhibits the production of
PQS (Calfee et al. 2001), and eugenol, the major compound
of clove extract, decreases the transcriptional activation of
P. aeruginosa las and pqs systems (Zhou et al. 2013). The
second group of strategies neutralizes QS signals by enzymat-
ic or antibody-mediated inactivation (Kalia and Purohit 2011).
QQ enzymes can either hydrolyze the AHL molecules, e.g.,
AHL-lactonase, or reduce carbonyl to hydroxyl groups by the
activity of oxidoreductases (Scutera et al. 2014). Long-acyl
AHLs are degraded with the participation of AHL-acylase
(Huang et al. 2003). The immunological approach includes
the use ofmonoclonal antibodies, such asAP4-24H11, against
S. aureus autoinducer (Park et al. 2007) or antibodies against
P. aeruginosa homoserine lactones (Palliyil et al. 2014). An-
other class of strategies explores compounds whose targets are
autoinducer–receptor interactions and/or receptor-mediated
signals. Synthetic brominated derivatives of furanone known
as C-30, AHL analogs, hamamelitannin, and also the extracts
of several common fruits, herbs, and spices inhibit QS recep-
tors, LasR and RhlR (Vattem et al. 2007; Sintim et al. 2010;
O’Loughlin et al. 2013). For example, clove oil inhibits Las-
and Rhl-regulated virulence factors, swimming motility, and
extracellular polymeric substance (EPS) production in
P. aeruginosa (Husain et al. 2013). In turn, solonamides iso-
lated from Photobacterium, due to their structural similarity to
agr AI, competitively inhibit the agr system in S. aureus
(Mansson et al. 2011). Yet another compound, a sesquiterpene
alcohol, farnesol, produced by Candida albicans and also
present in the essential oils of citrus fruits, affects biofilm
formation by P. aeruginosa, C. albicans, S. aureus, and Strep-
tococcus mutans by interfering with the transcription of QS
operons (Cugini et al. 2007; Jabra-Rizk et al. 2006). A number
of compounds were identified that target the response regula-
tor LuxO and the transcriptional repressor HtpR inV. cholerae.
One of the most potent is pyrrole analog precursor of cholerae
autoinducer 1, CA1 (Perez et al. 2014).
Several QS inhibitors can also enhance the activity of
existing antibiotics and restore immune response efficiency
(Jakobsen et al. 2012). For example, it was demonstrated that
the QS inhibitor, hamamelitannin, acts synergistically with van-
comycin or clindamycin against S. aureus (Brackman et al.
2011). It was also shown that biofilms treated with syn-
thetic furanone C-30 are susceptible to tobramycin and
readily dispersed by detergents (Hentzer et al. 2003).
Moreover, QS mutants and cells treated with QS inhib-
itors were found to be prone to oxidative burst and
phagocytosis (Bjarnsholt et al. 2005).
In our group, the trial was performed to evaluate the
inhibitory activity of nanosilver on the QS system in
P. aeruginosa. Silver nanoparticles were chosen due to
their strong antibacterial activity, pleiotropic effect on
bacterial cell, and lack of documented resistance devel-
opment (Markowska et al. 2013). Unfortunately, no
inhibition of QS LasI and Rhl1 systems was determined
(data not published).
Some researchers stress the advantages connected with the
use of QQ compounds. Because QS inhibitors do not exert a
direct bactericidal effect, it is commonly considered that there
is less selection pressure and less likelihood of resistance de-
velopment (Pan and Ren 2009). Unfortunately, recent evi-
dence indicates the development of the resistance to QS inhib-
itors in P. aeruginosa (Kalia et al. 2014). The increased resis-
tance exploits the efflux mechanisms, e.g., mexR and nalC
mutants demonstrated the increased resistance to C-30
(Maeda et al. 2012). The potential risk connected with the
use of all QQ strategies described above should also be men-
tioned. QS inhibitors can select more virulent strains by inter-
fering with natural selection towards reduced virulence (Köh-
ler et al. 2010). Moreover, the elimination of a particular path-
ogen can predispose patients to be infected with others.
As the prominent role of c-di-GMP is the activation of
biofilm formation, the signals that downregulate its concen-
tration in a cell can be considered potential anti-biofilm
agents. There are several approaches to interfere with c-di-
GMP signaling, e.g., manipulation with enzymatic activities,
interference with signal perception, and direct inactivation
(Römling and Balsalobre 2012). The inhibition of c-di-GMP
synthesizing activity or stimulation of phosphodiesterase ac-
tivity can diminish or enhance biofilm formation, respectively
(Chávez de Paz et al. 2012; An et al. 2010). There are no
natural compounds interfering with the synthesis or activity
of c-di-GMP, but among synthetic compounds, sulfathiazole
and N-(4-aminophenyl) benzamide were shown to be potent
inhibitors of biofilm formation, this being achieved by sup-
pressing diguanlyate cyclases (Antoniani et al. 2010). Several
inhibitors targeting diguanylate cyclases, named DCG inhibi-
tors, and, thus, influencing c-di-GMP metabolism in
V. cholerae were identified (Sambanthamoorthy et al. 2012,
2014). In turn, azathioprine interferes with intracellular nucle-
otide pool availability (Antoniani et al. 2013). Other signals
controlling the c-di-GMP level can also be used to regulate c-
di-GMP signaling. For example, P. aeruginosa exposure to
nitric oxide (NO) stimulates c-di-GMP-specific phosphodies-
terase activity, thus promoting biofilm dispersal (Barraud et al.
2009), whereas the sequestration of c-di-GMP by high-affinity
receptors removes the available nucleotide pool and promotes
biofilm dispersal, phenotypically mimicking phosphodiester-
ase activity (Ma et al. 2011). c-di-GMP stimulates biofilm
development only in a relatively narrow range of concentra-
tion; it was shown that extracellular c-di-GMP, when applied
in high concentration, acts as an inhibitor of biofilm formation
by S. aureus (Karaolis et al. 2005). It should also be men-
tioned that c-di-GMP and other cyclic di-nucleotides can serve
as potential adjuvants, and their high efficacy to stimulate an
immune response can constitute a future strategy to inhibit
biofilm formation (Karaolis et al. 2007).
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Targeting the regulatory sRNAs is another potential way to
modulate the expression of genes important for biofilm devel-
opment (Kang et al. 2014). Experiments performed with
E. coli have shown that the modulation of expression of sev-
eral sRNAs, OmrR, OmrB, and McaS, leading to the change
in cell motility, production of curli, and export of
exopolysaccharides, results in the inhibition of biofilm forma-
tion. Also, the knockout of other sRNAs, Arc2, SdsR, GadY,
and MicA, affects biofilm development and motility, although
their mode of action remains elusive (Mandin and Guillier
2013). Metabolic engineering and the possibility to synthesize
artificial RNAs of choice (Man et al. 2011) create the oppor-
tunity for the silencing of any specific gene and, therefore,
inhibit various steps of biofilm formation or enhance biofilm
dispersal.
Concluding remarks
The biofilm formation and dispersal in pathogenic bacteria has
been studied extensively, and a large number of literature po-
sitions dealing with these processes, including their genetic
regulation, has been published. The regulators being the sub-
ject of this paper, QS, c-di-GMP, and sRNA, are necessary for
biofilm biology in all four described bacterial species, but the
details of their regulatory role and the importance of the par-
ticular factor vary between species.
InP. aeruginosa and S. aureus, QS systems regulate mainly
biofilm dispersal, while in V. cholerae, QS is important for
biofilm formation, and it was proved that this process is in-
duced at low cell density. There are no available data on the
regulation of S. Typhimurium biofilm by QS. In turn, c-di-
GMP signaling is a factor regulating biofilm formation in
P. aeruginosa, S. Typhimurium, and V. cholerae, but its in-
volvement in the regulation of S. aureus biofilm is still con-
troversial. The interactions between QS and c-di-GMP regu-
latory pathways exist and are especially well documented for
V. cholerae. Finally, as the variety of sRNAs regulates the
large spectrum of bacterial genes, it can be expected that these
molecules can also be involved in biofilm biology. Indeed,
sRNAs have been shown to regulate post-transcriptionally,
usually negatively, biofilm formation in all four described
species. The interconnections between sRNAs and other reg-
ulators are proved.
The number of attempts to target genetic determinants in
order to modulate biofilms formed by bacterial pathogens is
growing exponentially. In the in vitro experiments, several
small-molecule therapeutics were discovered. They can be
divided into four classes: QS inhibitors, disruptors of c-di-
GMP signaling, inhibitors of sRNAs activity, and compounds
with unknown target. The technique combining microscopic
imaging with cellular viability measurements allows to iden-
tified the compound that selectively disrupt biofilm formation
without affecting cell survival (Teschler et al. 2015). All com-
pounds giving positive results during the in vitro studies
should pass preclinical and clinical trials in order to be accept-
ed in the therapy arena.
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